Improved solubilization of recombinant human growth hormone inclusion body produced in Escherichia coli

Bioscience, Biotechnology and Biochemistry

Volumn 72, Issue 10, 2008, Pages 2675-2680

  Sonoda, Hiroyuki ^a   Sugimura, Atsushi ^a  

^a JCR Pharmaceuticals Co   (Japan)

Author keywords

Escherichia coli; Human growth hormone; Inclusion body; Solubilization

Indexed keywords

AGGLOMERATION; CELL CULTURE; CELL PROLIFERATION; CHROMATOGRAPHIC ANALYSIS; COST EFFECTIVENESS; CYTOLOGY; ESCHERICHIA COLI; GEL PERMEATION CHROMATOGRAPHY; METABOLISM; UREA;

ALKALINE PHS; ALKALINE TREATMENTS; BIOLOGICAL ACTIVITIES; CELL LINES; EFFICIENT; GUANIDINE HYDROCHLORIDES; HUMAN GROWTH HORMONE; INCLUSION BODIES; INCLUSION BODY; PRODUCTION SYSTEMS; RECOMBINANT HUMAN GROWTH HORMONES; SEPHAROSE; SOLUBILIZATION; TRIS BUFFERS;

SOLUBILITY;

HUMAN GROWTH HORMONE; RECOMBINANT PROTEIN;

ARTICLE; CELL INCLUSION; ESCHERICHIA COLI; GENETICS; HEAT; HUMAN; METABOLISM; MICROBIAL VIABILITY; SOLUBILITY;

ESCHERICHIA COLI; HOT TEMPERATURE; HUMAN GROWTH HORMONE; HUMANS; INCLUSION BODIES; MICROBIAL VIABILITY; RECOMBINANT PROTEINS; SOLUBILITY;

ESCHERICHIA COLI;

EID: 55049133746     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80332     Document Type: Article

References (23)

1. Baneyx, F., Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol., 10, 411-421 (1999).
2. Swartz, J. R., Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol., 12, 195-201 (2001).
3. Kane, J. F., and Hartley, D. L., Formation of recombinant protein inclusion bodies in Escherichia coli. Trends Biotechnol., 6, 95-101 (1988).
4. Mitraki, A., and King, J., Protein folding intermediates and inclusion body formation. Biotechnology (NY), 7, 690-697 (1989).
5. Schein, C. H., Production of soluble recombinant proteins in bacteria. Biotechnology (NY), 7, 1141-1149 (1989).
6. Fischer, B., Sumner, I., and Goodenough, P., Isolation, renaturation and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. Biotechnol. Bioeng., 41, 3-13 (1993).
7. Sadana, A., Protein refolding and inactivation during bioseparation: bioprocessing implications. Biotechnol. Bioeng., 48, 481-489 (1995).
8. Ganong, W. F., The pituitary gland. In "Review of Medical Physiology" 11th edn., ed. Ganog, W. F., Lange, Los Altos, pp. 323-335 (1983).
9. Iglesias, P., and Díez, J. J., Clinical applications of recombinant human growth hormone in adults. Expert Opin. Pharmacother., 1, 97-107 (1999).
10. Kato, C., Kobayashi, T., Kubo, T., Furusato, T., Murakami, Y., Tanaka, T., Baba, T., Oishi, T., Ikehara, M., Yanagida, T., Kato, H., Moriyama, T., and Horikoshi, K., Construction of an excretion vector and extracellular production of human growth hormone from Escherichia coli. Gene, 54, 197-202 (1987).
11. Mukhija, R., Rupa, P., Pillai, D., and Garg, L. C., High-level production and one-step purification of biologically active human growth hormone in Escherichia coli. Gene, 165, 303-306 (1995).
12. Rudolph, R., and Lilie, H., In vitro folding of inclusion body proteins. FASEB J., 10, 49-56 (1996).
13. Datar, R. V., Cartwright, T., and Rosen, C. G., Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator. Biotechnology (NY), 11, 349-357 (1993).
14. Patra, A. K., Mukhopadhyay, R., Mukhija, R., Krishnan, A., Garg, L. C., and Panda, A. K., Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr. Purif., 18, 182-192 (2000).
15. Singh, S. M., and Panda, A. K., Solubilization and refolding of bacterial inclusion body proteins. J. Biosci. Bioeng., 99, 303-310 (2005).
16. Matsui, T., Sato, H., Sato, S., Mukataka, S., and Takahashi, J., Effects of nutritional conditions on plasmid stability and production of tryptophan synthase by a recombinant Escherichia coli. Agric. Biol. Chem., 54, 619-624 (1990).
17. Matsui, T., Yokota, H., Sato, S., Mukataka, S., and Takahashi, J., Pressurized culture of Escherichia coli for a high concentration. Agric. Biol. Chem., 53, 2115-2120 (1989).
18. Tabandeh, F., Shojaosadati, S. A., Zomorodipour, A., Khodabandeh, M., Sanati, M. H., and Yakhchali, B., Heat-induced production of human growth hormone by high cell density cultivation of recombinant Escherichia coli. Biotechnol. Lett., 26, 245-250 (2004).
19. Enfors, S. O., Control of in vivo proteolysis in the production of recombinant proteins. Trends Biotechnol., 10, 310-315 (1992).
20. Rinas, U., Synthesis rates of cellular proteins involved in translation and protein folding are strongly altered in response to overproduction of basic fibroblast growth factor by recombinant Escherichia coli. Biotechnol. Prog., 12, 196-220 (1996).
21. Khan, R. H., Rao, K. B., Eshwari, A. N., Toney, S. M., and Panda, A. K., Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of E. coli. Biotechnol. Prog., 14, 722-728 (1998).
22. Shin, N. K., Kim, D. Y., Shin, C. S., Hong, M. S., Lee, J., and Shin, H. C., High-level production of human growth hormone in Escherichia coli by a simple recombinant process. J. Biotechnol., 62, 143-151 (1998).
23. Storrs, S. B., and Przybycien, T. M., Commercial-scale refolding of recombinant methionyl bovine somatotropin. In "Protein Refolding," eds. Georgiou, G., and De Bernardez-Clark, E., ACS Symposium Series No. 470, Am. Chem. Soc., Washington, DC, pp. 197-205 (1991).